Moors & Cabot, Inc. Zoetis Inc. Transaction History

Moors & Cabot, Inc.

$1.85 Billion
Q2 2024

A detailed history of Moors & Cabot, Inc. transactions in Zoetis Inc. stock. As of the latest transaction made, Moors & Cabot, Inc. holds 14,709 shares of ZTS stock, worth $2.67 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

14,709

Previous 14,455 1.76%

Holding current value

$2.67 Million

Previous $2.45 Million 4.25%

% of portfolio

0.14%

Previous 0.13%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$145.54 - $178.83 $36,967 - $45,422	254 Added 1.76%	14,709 $2.55 Million
Q1 2024 May 08, 2024	SELL	$165.67 - $199.94 $315,932 - $381,285	-1,907 Reduced 11.66%	14,455 $2.45 Million
Q4 2023 Feb 14, 2024	SELL	$151.44 - $200.09 $9,843 - $13,005	-65 Reduced 0.4%	16,362 $3.23 Million
Q3 2023 Nov 07, 2023	BUY	$167.14 - $192.77 $24,903 - $28,722	149 Added 0.92%	16,427 $2.86 Million
Q2 2023 Aug 09, 2023	BUY	$160.94 - $186.23 $53,432 - $61,828	332 Added 2.08%	16,278 $2.8 Million
Q1 2023 May 04, 2023	SELL	$145.48 - $175.02 $303,180 - $364,741	-2,084 Reduced 11.56%	15,946 $2.65 Million
Q4 2022 Feb 09, 2023	SELL	$131.14 - $157.47 $54,947 - $65,979	-419 Reduced 2.27%	18,030 $2.64 Million
Q4 2022 Feb 06, 2023	BUY	$131.14 - $157.47 $84,454 - $101,410	644 Added 3.62%	18,449 $2.7 Million
Q3 2022 Nov 07, 2022	SELL	$148.29 - $182.55 $64,209 - $79,044	-433 Reduced 2.37%	17,805 $2.64 Million
Q2 2022 Aug 08, 2022	SELL	$155.97 - $200.09 $1,247 - $1,600	-8 Reduced 0.04%	18,238 $3.14 Million
Q1 2022 May 13, 2022	SELL	$181.39 - $234.03 $18,683 - $24,105	-103 Reduced 0.56%	18,246 $3.44 Million
Q4 2021 Feb 14, 2022	SELL	$193.69 - $247.03 $38,544 - $49,158	-199 Reduced 1.07%	18,349 $4.48 Million
Q3 2021 Dec 08, 2021	BUY	$189.29 - $209.69 $3.51 Million - $3.89 Million	18,548 New	18,548 $3.6 Million
Q3 2021 Nov 05, 2021	SELL	$189.29 - $209.69 $3.51 Million - $3.88 Million	-18,527 Closed	0 $0
Q2 2021 Aug 10, 2021	BUY	$155.9 - $187.99 $53,161 - $64,104	341 Added 1.88%	18,527 $3.45 Million
Q1 2021 May 12, 2021	SELL	$144.0 - $169.39 $213,408 - $251,035	-1,482 Reduced 7.54%	18,186 $2.86 Million
Q4 2020 Feb 11, 2021	SELL	$157.07 - $174.35 $105,079 - $116,640	-669 Reduced 3.29%	19,668 $3.27 Million
Q3 2020 Nov 09, 2020	SELL	$137.1 - $165.37 $12,064 - $14,552	-88 Reduced 0.43%	20,337 $3.36 Million
Q2 2020 Aug 13, 2020	BUY	$111.92 - $142.53 $267,376 - $340,504	2,389 Added 13.25%	20,425 $2.8 Million
Q1 2020 May 12, 2020	SELL	$92.66 - $144.94 $611,556 - $956,604	-6,600 Reduced 26.79%	18,036 $2.13 Million
Q4 2019 Jan 28, 2020	SELL	$116.25 - $133.25 $13,136 - $15,057	-113 Reduced 0.46%	24,636 $3.26 Million
Q3 2019 Oct 22, 2019	BUY	$112.57 - $128.43 $767,389 - $875,507	6,817 Added 38.02%	24,749 $3.09 Million
Q2 2019 Jul 18, 2019	BUY	$97.98 - $114.28 $141,777 - $165,363	1,447 Added 8.78%	17,932 $2.03 Million
Q1 2019 May 06, 2019	SELL	$81.56 - $100.67 $1.34 Million - $1.66 Million	-16,485 Reduced 50.0%	16,485 $1.65 Million
Q1 2019 May 01, 2019	BUY	$81.56 - $100.67 $1.21 Million - $1.5 Million	14,890 Added 82.36%	32,970 $3.31 Million
Q4 2018 Feb 13, 2019	BUY	$79.28 - $95.27 $64,375 - $77,359	812 Added 4.7%	18,080 $1.55 Million
Q3 2018 Nov 14, 2018	SELL	$83.5 - $93.23 $106,379 - $118,775	-1,274 Reduced 6.87%	17,268 $1.58 Million
Q2 2018 Aug 14, 2018	BUY	$79.9 - $89.2 $89,408 - $99,814	1,119 Added 6.42%	18,542 $1.59 Million
Q1 2018 May 18, 2018	BUY	$71.51 - $84.69 $112,699 - $133,471	1,576 Added 9.95%	17,423 $1.46 Million
Q4 2017 Feb 13, 2018	BUY	$63.24 - $72.8 $11,256 - $12,958	178 Added 1.14%	15,847 $1.14 Million
Q3 2017 Nov 16, 2017	BUY	$59.73 - $65.4 $41,811 - $45,780	700 Added 4.68%	15,669 $1 Million
Q2 2017 Aug 15, 2017	BUY	N/A	14,969	14,969 $929,000

Others Institutions Holding ZTS

# of Institutions

1,919

Shares Held

424M

Call Options Held

1.15M

Put Options Held

1.2M

View Full List

About Zoetis Inc.

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $84.9B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

More about ZTS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Moors & Cabot, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Moors & Cabot, Inc. with notifications on news.

Account